We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UBSG:SIXUBS Group AG Analysis

Data as of 2026-03-09 - not real-time

CHF 29.62

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

UBS Group AG is trading at CHF 29.62, well below its 20‑day (CHF 31.90) and 50‑day (CHF 34.94) simple moving averages, indicating short‑term weakness, yet the Relative Strength Index of 25.3 suggests the stock is oversold and may be primed for a rebound. Technical momentum is bearish with a MACD histogram below the signal line, but volume is increasing, hinting at emerging buying pressure near the support level of CHF 28.97. On the fundamentals side, the forward price‑to‑earnings ratio of 9.66 is markedly lower than the industry average of 17.38, and the current PE of 16.1 also undercuts peers, positioning the stock as undervalued. The company boasts a solid capital structure with CHF 532 bn in cash offsetting CHF 525 bn of debt, a dividend yield of 2.86% backed by a 38% payout ratio, and a revenue growth rate of 5.5% YoY. Analyst consensus is a “buy” with a median target of CHF 38, implying roughly a 29% upside, while the Fear & Greed Index is at “Extreme Greed,” reflecting strong market sentiment.
Given the high 30‑day volatility of nearly 29% but a low beta around 0.43, UBS’s price moves are more idiosyncratic than market‑driven, reducing systematic risk. The banking sector carries medium regulatory exposure, and UBS’s global footprint introduces moderate geographic and currency risks, though its Swiss domicile offers stability. Overall, the blend of attractive valuation, sustainable dividend, and strategic growth initiatives—particularly the Asia wealth push—supports a positive outlook across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • RSI indicates oversold conditions
  • Price is near technical support
  • Increasing volume suggests buying interest

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward PE of 9.66 vs industry 17.38
  • Dividend yield 2.86% with sustainable payout
  • Analyst consensus buy and median target price of CHF 38

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strong net cash position offsetting debt
  • Diversified revenue streams across wealth and investment banking
  • Strategic expansion in Asian wealth management

Key Metrics & Analysis

Financial Health

Revenue Growth5.50%
Profit Margin15.83%
P/E Ratio16.1
ROE8.86%
ROA0.49%
P/B Ratio1.3
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI25.3
SupportCHF 28.97
ResistanceCHF 34.09
MA 20CHF 31.90
MA 50CHF 34.94
MA 200CHF 31.56
MACDBearish
VolumeIncreasing
Fear & Greed Index100

Valuation

Target PriceCHF 38.20
Upside/Downside28.96%
GradeUndervalued
TypeBlend
Dividend Yield2.86%

Risk Assessment

Beta0.43
Volatility28.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.